Comparison of Cisplatin and Nitrogen Mustard Derivatives in Cancer Treatment
Format
Oral Presentation
Faculty Mentor Name
Qinliang Zhao
Faculty Mentor Department
Chemistry
Abstract/Artist Statement
Platinum-containing complexes and nitrogen mustard derivatives are two drug families for cancer treatment. The two core drugs of the families were Cisplatin, created in 1845, and Chlormethine (mustine), created in 1925. Cisplatin is used to treat cancers like ovarian, breast, lung, esophageal, and many more. Nitrogen mustards are used as palliative care in lung and breast cancers as well as treatment for Hodgkin’s disease. The two families of drugs in treating cancer will be compared in terms of mechanism, side effects, and resistance factors. The report will also focus on the importance of the Pt metal in cancer treatment.
Location
University of the Pacific, 3601 Pacific Ave., Stockton, CA 95211
Start Date
24-4-2021 4:00 PM
End Date
24-4-2021 4:15 PM
Comparison of Cisplatin and Nitrogen Mustard Derivatives in Cancer Treatment
University of the Pacific, 3601 Pacific Ave., Stockton, CA 95211
Platinum-containing complexes and nitrogen mustard derivatives are two drug families for cancer treatment. The two core drugs of the families were Cisplatin, created in 1845, and Chlormethine (mustine), created in 1925. Cisplatin is used to treat cancers like ovarian, breast, lung, esophageal, and many more. Nitrogen mustards are used as palliative care in lung and breast cancers as well as treatment for Hodgkin’s disease. The two families of drugs in treating cancer will be compared in terms of mechanism, side effects, and resistance factors. The report will also focus on the importance of the Pt metal in cancer treatment.